Cooper Companies Q3 EPS $1.15 Beats by $0.03; Revenue Misses at $1.07B
Medical device maker Cooper Companies posted Q3 FY2026 EPS of $1.15, topping the $1.12 consensus, but revenue of $1.07B fell short of the $1.10B estimate. For healthcare executives, the mixed print highlights margin strength against slowing top-line growth in the device sector.